Evofem Biosciences, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Evofem Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q3 2024.
  • Evofem Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$8K, a 173% decline year-over-year.
  • Evofem Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $17K, a 61.4% decline from 2022.
  • Evofem Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $44K, a 159% increase from 2021.
  • Evofem Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $17K, a 325% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8K -$19K -173% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $8K +$5K +167% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q4 2023 $17K $0 -$8K -100% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $25K $11K -$2K -15.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $27K $3K -$17K -85% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $44K $3K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $44K $8K +$2K +33.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $42K $13K +$13K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $29K $20K +$8K +66.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $21K $3K +$4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-06-16
Q4 2021 $17K $6K +$4K +200% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-27
Q3 2021 $13K $0 -$2K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2023-01-06
Q2 2021 $15K $12K +$12K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $3K -$1K -$1K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $4K $2K +$2K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $2K $2K +$2K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 $0 -$4K -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $4K $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $4K $0 $0 Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $4K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $4K $4K +$2K +100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $2K $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2K $0 $0 Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $2K $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $2K $2K +$2K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $0 $0 -$3K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $3K $0 Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $3K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.